All Deals
March 6, 2025 - Deals
Andy Lowery Acquires Property From Epirus
Epirus, a Torrance, CA-based defense technology company led by CEO Andy Lowery, raised $250M in Series D funding led by 8VC and Washington Harbour Partners LP, with participation from General Dynamics Land Systems, T. Rowe Price, and others. The company is developing Leonidas™, a high-power microwave platform for counter-electronics warfare, proven effective in Department of Defense tests. The funding will support talent acquisition, supply chain improvements, and U.S. manufacturing expansion, including a new simulation center opening in Oklahoma in Q3 2025.
INVESTORS: 8VC, Washington Harbour Partners LP, StepStone Group, funds and accounts advised by T. Rowe Price Investment Management, Inc., Gaingels, General Dynamics Land Systems, Oppenheimer’s Private Market Opportunities Vista VI Fund, NightDragon, Manhattan Venture Partners, Centaurus Capital LP & Center15 Capital
ROUND: Series D
AMOUNT: $250,000,000
HQ: #Torrance #California
#VentureCapital #Epirus #AndyLowery #8VC #WashingtonHarbourPartnersLP #StepStoneGroup #TRowePrice #Gaingels #GeneralDynamicsLandSystems #OppenheimerPrivateMarketOpportunitiesVistaVIFund #NightDragon #ManhattanVenturePartners #CentaurusCapitalLP #Center15Capital #TradedVC
More Deals
View All
Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts.
FOUNDERS: Ben Lamm & George Church
TARGET VALUATION: $23,000,000,000
HQ: Dallas, Texas
#VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC